DELETION OF BONE MARROW OR NON-BONE MARROW DERIVED RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS ATTENUATES DIABETES-ASSOCIATED ATHEROSCLEROSIS

被引：0
|
作者：
Koulis, C. [1 ]
Kanellakis, P. [1 ]
Pickering, R. J. [1 ]
Tsorotes, D. [1 ]
Thomas, M. C. [1 ]
Cooper, M. E. [1 ]
Jandeleit-Dahm, K. A. [1 ]
Allen, T. J. [1 ]
机构：
[1] Baker IDI Heart & Diabet Res Inst, Melbourne, Vic, Australia
来源：
HYPERTENSION | 2014年 / 63卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E168 / E168
页数：1
相关论文
共 50 条
  • [21] Advanced Glycation End Products: Do They Impair Bone Health in Diabetes?
    Papachristou, Stella
    Rizzo, Manfredi
    Papanas, Nikolaos
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2022, 130 (10) : 636 - 637
  • [22] Hepatocyte growth factor mobilizes non-bone marrow-derived circulating mesoangioblasts
    Iwasaki, Masayoshi
    Koyanagi, Masamichi
    Kossmann, Hans
    Monsefi, Nadejda
    Rupp, Stefan
    Trauth, Janina
    Paulus, Patrick
    Goetz, Rebekka
    Momma, Stefan
    Tjwa, Marc
    Ohtani, Kisho
    Henschler, Reinhard
    Schranz, Dietmar
    Cossu, Giulio
    Zacharowski, Kai
    Martens, Sven
    Zeiher, Andreas M.
    Dimmeler, Stefanie
    EUROPEAN HEART JOURNAL, 2011, 32 (05) : 627 - 636
  • [23] Methylglyoxal induced advanced glycation end products (AGE)/receptor for AGE (RAGE)-mediated angiogenic impairment in bone marrow-derived endothelial progenitor cells
    Kim, Jeong-Hyeon
    Kim, Kyeong-A
    Shin, Young-Jun
    Kim, Haram
    Majid, Arshad
    Bae, Ok-Nam
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2018, 81 (09): : 266 - 277
  • [24] Both bone marrow- and non-bone marrow-associated factors determine susceptibility to experimental autoimmune encephalomyelitis of BUF and WAG rats
    vanGelder, M
    KinwelBohre, EPM
    Mulder, AH
    vanBekkum, DW
    CELLULAR IMMUNOLOGY, 1996, 168 (01) : 39 - 48
  • [25] Irbesartan attenuates advanced glycation end products-mediated damage in diabetes-associated osteoporosis through the AGEs/RAGE pathway
    Cheng, Yan-Zhen
    Yang, Shuang-Li
    Wang, Ji-Yu
    Ye, Meng
    Zhuo, Xiao-Yun
    Wang, Li-Tao
    Chen, Hong
    Zhang, Hua
    Yang, Li
    LIFE SCIENCES, 2018, 205 : 184 - 192
  • [26] Deletion of the receptor for advanced glycation end products, RAGE, protects from diabetic nephropathy and atherosclerosis
    Jandeleit-Dahm, K. A. M.
    Yong, J.
    Jiaze, L.
    Barit, D.
    Soro-Paavonen, A.
    Giunti, S.
    Watson, A.
    Bierhaus, A.
    Allen, T.
    Cooper, M.
    DIABETOLOGIA, 2008, 51 : S44 - S44
  • [27] CD44 expressed on both bone marrow-derived and non-bone marrow-derived cells promotes atherogenesis in ApoE-deficient mice
    Zhao, Liang
    Lee, Eric
    Zukas, Alicia M.
    Middleton, Melissa K.
    Kinder, Michelle
    Acharya, Pinak S.
    Hall, Jason A.
    Rader, Daniel J.
    Pure, Ellen
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (07) : 1283 - 1289
  • [28] Receptor for Advanced Glycation End Products-Mediated Signaling Impairs the Maintenance of Bone Marrow Mesenchymal Stromal Cells in Diabetic Model Mice
    Aikawa, Eriko
    Fujita, Ryo
    Asai, Maiko
    Kaneda, Yasufumi
    Tamai, Katsuto
    STEM CELLS AND DEVELOPMENT, 2016, 25 (22) : 1721 - 1732
  • [29] An essential role for non-bone marrow-derived cells in control of Pseudomonas aeruginosa pneumonia
    Hajjar, AM
    Harowicz, H
    Liggitt, HD
    Fink, PJ
    Wilson, CB
    Skerrett, SJ
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2005, 33 (05) : 470 - 475
  • [30] NON-BONE MARROW DERIVED CELLS PROVOKE REJECTION ACROSS CLASS-II DIFFERENCES
    STUART, PM
    BECKMAIER, B
    MELVOLD, RW
    FEDERATION PROCEEDINGS, 1983, 42 (04) : 936 - 936
12345